Alaunos Therapeutics | ZIOP - Vertriebs- Und Verwaltungskosten





Vertriebs- Und Verwaltungskosten Veränderung Datum
Alaunos Therapeutics USD 585K 84K 2025-09
Amgen USD 1.94B 237M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Baxter International USD 761M 53M 2025-12
Biogen USD 545.2M 38.6M 2025-09
Bioline Rx USD 831K 622K 2025-09
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Celltrion KRW 249.98B 16.36B 2025-09
Corcept Therapeutics USD 114.74M 7.77M 2025-12
Cspc Pharmaceutical CNY 1.87B 95.62M 2025-12
Curis USD 1.34M 3.45M 2025-12
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 6.57M 1.62M 2025-12
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Gilead Sciences USD 1.78B 425M 2025-12
GlaxoSmithKline GBP 2.68B 518M 2025-12
Incyte USD 390.41M 61.33M 2025-12
Intrexon USD 10.31M 41K 2024-06
Ionis Pharmaceuticals USD 130M 43.43M 2025-12
J&J USD 6.75B 831M 2025-12
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Merck USD 2.85B 215M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Novartis USD 3.44B 128M 2025-12
Organigram Holdings CAD 7.73M 1.13M 2025-12
Ovoca Bio EUR 632K 2.33M 2025-06
Pfizer USD 4.08B 894M 2025-12
Pharma Mar EUR 17.31M 3.6M 2025-12
PTC Therapeutics USD 87.2M 3.15M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Sartorius EUR 218.7M 6.5M 2025-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
TG Therapeutics USD 50.73M 12.64M 2025-12
Tilray USD 24.85M 1.7M 2025-09
Verastem USD 24.44M 12.17M 2025-12
Zealand Pharma A/S 91.81M 99.04M 2025-12
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09